RegeneRx Biopharmaceuticals Inc RGRX:OTCQB

RT Quote | Exchange | USD
Last | 3:38 PM EDT
0.195quote price arrow up+0.005 (+2.63%)
Volume
5,000
52 week range
0.10 - 0.45
Loading...
  • Open0.195
  • Day High0.195
  • Day Low0.195
  • Prev Close0.19
  • 52 Week High0.45
  • 52 Week High Date10/06/21
  • 52 Week Low0.10
  • 52 Week Low Date04/29/22

Key Stats

  • Market Cap27.99M
  • Shares Out143.55M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.25
  • YTD % Change21.88

KEY STATS

  • Open0.195
  • Day High0.195
  • Day Low0.195
  • Prev Close0.19
  • 52 Week High0.45
  • 52 Week High Date10/06/21
  • 52 Week Low0.10
  • 52 Week Low Date04/29/22
  • Market Cap27.99M
  • Shares Out143.55M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.25
  • YTD % Change21.88

RATIOS/PROFITABILITY

  • EPS (TTM)-0.01
  • P/E (TTM)-16.96
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-1.329M
  • ROE (TTM)-
  • Revenue (TTM)80,000.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-2,081.50%
  • Debt To Equity (MRQ)-50.99%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On RegeneRx Biopharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
RegeneRx Biopharmaceuticals, Inc.(RegeneRx) is a biopharmaceutical company. The RegeneRx is focused on the development of a therapeutic peptide Thymosin beta 4(Tb4) for tissue and organ protection, repair, and regeneration. RegeneRx operates in the development and marketing of Tb4, an amino acid peptide. Tb4 is a synthetic copy of a naturally occurring 43-amino acid peptid originally isolated from bovine thymus glands. The Company's product candidates in clinical development...
Allan Goldstein Ph.D.
Chairman of the Board, Founder, Chief Scientific Officer
J. Finkelstein
President, Chief Executive Officer, Director
Address
15245 Shady Grove Rd Ste 470
Rockville, MD
20850-6243
United States

Top Peers

SYMBOLLASTCHG%CHG
CLBS
Caladrius Biosciences Inc
0.4571-0.0029-0.6304%
ADIL
Adial Pharmaceuticals Inc
1.36-0.12-8.11%
ELOX
Eloxx Pharmaceuticals Inc
0.2935-0.014-4.5528%
CRBP
Corbus Pharmaceuticals Holdings Inc
0.33+0.0338+11.41%
APRE
Aprea Therapeutics Inc
0.6251-0.0519-7.6662%
PCSA
Processa Pharmaceuticals Inc
2.17+0.28+14.81%